Next Article in Journal
Optimization of Liposomes for Antigen Targeting to Splenic CD169+ Macrophages
Next Article in Special Issue
Drug Disposition in the Lower Gastrointestinal Tract: Targeting and Monitoring
Previous Article in Journal
Novel Solid Dispersions of Naphthoquinone Using Different Polymers for Improvement of Antichagasic Activity
Previous Article in Special Issue
Bottom-Up Physiologically Based Oral Absorption Modeling of Free Weak Base Drugs
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 12
Issue 12
10.3390/pharmaceutics12121137
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Erratum to Pharmaceutics 2020, 12(6), 566.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Erratum

Erratum: Hens, B.; et al. Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola® on the Luminal and Systemic Behavior of Loratadine (BCS Class 2b). Pharmaceutics, 2020, 12, 566

by
Bart Hens
1,2,†,
Marival Bermejo
1,3,†,
Patrick Augustijns
2,
Rodrigo Cristofoletti
4,
Gregory E. Amidon
1 and
Gordon L. Amidon
1,*
1
Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109-1065, USA
2
Department of Pharmaceutical and Pharmacological Sciences, Faculty of Pharmaceutical Sciences, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
3
Department Engineering Pharmacy Section, Miguel Hernandez University, San Juan de Alicante, 03550 Alicante, Spain
4
Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, FL 32827, USA
*
Author to whom correspondence should be addressed.
†
Bart Hens & Marival Bermejo should both be considered as a joint first author.
Pharmaceutics 2020, 12(12), 1137; https://doi.org/10.3390/pharmaceutics12121137
Submission received: 1 September 2020 / Revised: 10 November 2020 / Accepted: 11 November 2020 / Published: 25 November 2020
(This article belongs to the Special Issue Mechanistic In Vitro and In Silico Modeling of Oral Drug Absorption)
Versions Notes
The authors make the following correction to this paper after the final publication of the work [1]: The authors acknowledge that Dr. Patrick Augustijns should have been included as one of the co-authors because of the conceptualization of the work with respect to the subject ‘real-life dosing conditions’.
The Author Contributions section has been updated as follows: B.H. and M.B. designed the experiments. Experimental work and ADMET Predictor simulations were performed by B.H. and M.B. performed the modeling experiments. P.A. conceptualized the research subject. G.L.A and G.E.A. supervised and co-financed the project. R.C. reviewed and edited the manuscript. All authors have read and agreed to the published version of the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

Reference

  1. Hens, B.; Bermejo, M.; Augustijns, P.; Cristofoletti, R.; Amidon, G.E.; Amidon, G.L. Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola® on the Luminal and Systemic Behavior of Loratadine (BCS Class 2b). Pharmaceutics 2020, 12, 566. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Hens, B.; Bermejo, M.; Augustijns, P.; Cristofoletti, R.; Amidon, G.E.; Amidon, G.L. Erratum: Hens, B.; et al. Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola® on the Luminal and Systemic Behavior of Loratadine (BCS Class 2b). Pharmaceutics, 2020, 12, 566. Pharmaceutics 2020, 12, 1137. https://doi.org/10.3390/pharmaceutics12121137

AMA Style

Hens B, Bermejo M, Augustijns P, Cristofoletti R, Amidon GE, Amidon GL. Erratum: Hens, B.; et al. Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola® on the Luminal and Systemic Behavior of Loratadine (BCS Class 2b). Pharmaceutics, 2020, 12, 566. Pharmaceutics. 2020; 12(12):1137. https://doi.org/10.3390/pharmaceutics12121137

Chicago/Turabian Style

Hens, Bart, Marival Bermejo, Patrick Augustijns, Rodrigo Cristofoletti, Gregory E. Amidon, and Gordon L. Amidon. 2020. "Erratum: Hens, B.; et al. Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola® on the Luminal and Systemic Behavior of Loratadine (BCS Class 2b). Pharmaceutics, 2020, 12, 566" Pharmaceutics 12, no. 12: 1137. https://doi.org/10.3390/pharmaceutics12121137

APA Style

Hens, B., Bermejo, M., Augustijns, P., Cristofoletti, R., Amidon, G. E., & Amidon, G. L. (2020). Erratum: Hens, B.; et al. Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola® on the Luminal and Systemic Behavior of Loratadine (BCS Class 2b). Pharmaceutics, 2020, 12, 566. Pharmaceutics, 12(12), 1137. https://doi.org/10.3390/pharmaceutics12121137

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop